Insider Selling: Health Catalyst (NASDAQ:HCAT) General Counsel Sells 70,000 Shares of Stock

Health Catalyst, Inc. (NASDAQ:HCAT) General Counsel Benjamin Landry sold 70,000 shares of Health Catalyst stock in a transaction on Wednesday, November 11th. The stock was sold at an average price of $1.43, for a total value of $100,100.00. Following the sale, the general counsel owned 281,372 shares of the company’s stock, valued at approximately $402,361.96. This trade represents a 19.92% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Benjamin Landry also recently made the following trade(s):

• On Thursday, November 12th, Benjamin Landry sold 29,478 shares of Health Catalyst stock. The shares were sold at an average price of $1.39, for a total transaction of $40,974.42.

Health Catalyst Trading Up 10.3%

Shares of NASDAQ HCAT traded up $0.14 during mid-day trading on Friday, reaching $1.50. The company had a trading volume of 465,291 shares, compared to its average volume of 920,868. The stock has a market cap of $114.22 million, a price-to-earnings ratio of -0.53 and a beta of 1.52. Health Catalyst, Inc. has a 52 week low of $0.96 and a 52 week high of $3.02. The business’s 50-day moving average is $1.69 and its 200-day moving average is $1.69.

Health Catalyst (NASDAQ:HCAT) last announced its quarterly earnings data on Thursday, November 5th. The company reported ($0.03) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.02. The company had revenue of $56.28 million during the quarter, compared to analyst estimates of $55.39 million. Health Catalyst had a negative net margin of 74.24% and a negative return on equity of 4.84%. As a group, equities research analysts forecast that Health Catalyst, Inc. will post -0.18 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts have commented on the company. Wells Fargo & Company reduced their price objective on Health Catalyst from $1.75 to $1.50 and set an “equal weight” rating on the stock in a report on Thursday, August 13th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Health Catalyst in a report on Monday, October 26th. Canaccord Genuity Group downgraded Health Catalyst from a “buy” rating to a “hold” rating and dropped their price target for the stock from $3.00 to $1.80 in a research report on Thursday, August 20th. Finally, Citigroup cut their price target on Health Catalyst from $2.50 to $2.00 and set a “neutral” rating on the stock in a research note on Tuesday, August 11th. Five equities research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Health Catalyst presently has a consensus rating of “Reduce” and a consensus target price of $2.01.

Institutional Trading of Health Catalyst

A number of hedge funds have recently bought and sold shares of the stock. Palogic Value Management L.P. purchased a new stake in shares of Health Catalyst during the 2nd quarter worth $9,796,000. BlackRock Inc. bought a new stake in Health Catalyst during the second quarter valued at about $3,654,000. Hsbc Holdings PLC bought a new stake in Health Catalyst during the second quarter valued at about $809,000. Squarepoint Ops LLC grew its stake in Health Catalyst by 1,214.8% in the second quarter. Squarepoint Ops LLC now owns 400,210 shares of the company’s stock valued at $796,000 after purchasing an additional 369,772 shares during the last quarter. Finally, Renaissance Technologies LLC purchased a new position in Health Catalyst in the first quarter valued at about $276,000. Hedge funds and other institutional investors own 85.00% of the company’s stock.

About Health Catalyst

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its solutions are designed to help providers use clinical, operational, and financial data to support decision-making and improve care delivery. The company’s offerings include a data platform that brings together information from multiple sources, analytics applications for healthcare workflows, and professional services. These services can include implementation, data management, and support for organizations developing and applying analytics programs.